Stock 4117 GENERAL BIOLOGICALS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials General Biologicals Corporation

Equities

4117

TW0004117007

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-05-12 EDT 		5-day change 1st Jan Change
19.65 TWD -0.76% Intraday chart for General Biologicals Corporation -2.72% -27.22%
04-30 General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 470.9 455.5 3,231 2,082 1,609 1,615
Enterprise Value (EV) 1 490.7 550.5 2,822 2,163 1,727 1,947
P/E ratio -6.69 x -11.5 x 45.8 x 47.2 x -30.2 x -8.13 x
Yield - - - - - -
Capitalization / Revenue 1.93 x 1.9 x 6.79 x 3.77 x 4.34 x 6.1 x
EV / Revenue 2.01 x 2.3 x 5.93 x 3.92 x 4.66 x 7.35 x
EV / EBITDA -11.4 x -36.5 x 44.5 x 33.3 x -76.1 x -14.6 x
EV / FCF -17.3 x 65.4 x 1,440 x 79.2 x -5.92 x 6.67 x
FCF Yield -5.77% 1.53% 0.07% 1.26% -16.9% 15%
Price to Book 4.71 x 6.33 x 4.72 x 2.85 x 2.33 x 3.27 x
Nbr of stocks (in thousands) 38,886 39,886 59,824 59,824 59,824 59,824
Reference price 2 12.11 11.42 54.00 34.80 26.90 27.00
Announcement Date 19-04-30 20-04-30 21-04-29 22-04-27 23-04-28 24-04-30
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 243.8 239.7 475.9 551.7 370.5 264.8
EBITDA 1 -43.09 -15.08 63.47 64.95 -22.69 -133.3
EBIT 1 -63.01 -34.54 43.37 43.79 -40.87 -169.9
Operating Margin -25.84% -14.41% 9.11% 7.94% -11.03% -64.17%
Earnings before Tax (EBT) 1 -68.73 -39.05 48.29 38.61 -46.13 -187.7
Net income 1 -69.22 -39.05 62.15 44.14 -53.19 -198.8
Net margin -28.39% -16.29% 13.06% 8% -14.36% -75.08%
EPS 2 -1.810 -0.9891 1.178 0.7379 -0.8900 -3.320
Free Cash Flow 1 -28.33 8.424 1.959 27.32 -291.8 291.7
FCF margin -11.62% 3.52% 0.41% 4.95% -78.77% 110.16%
FCF Conversion (EBITDA) - - 3.09% 42.06% - -
FCF Conversion (Net income) - - 3.15% 61.89% - -
Dividend per Share - - - - - -
Announcement Date 19-04-30 20-04-30 21-04-29 22-04-27 23-04-28 24-04-30
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 19.8 95.1 - 80.7 118 331
Net Cash position 1 - - 409 - - -
Leverage (Debt/EBITDA) -0.4584 x -6.304 x - 1.242 x -5.19 x -2.486 x
Free Cash Flow 1 -28.3 8.42 1.96 27.3 -292 292
ROE (net income / shareholders' equity) -52.5% -45.5% 16.3% 6.2% -7.54% -33.6%
ROA (Net income/ Total Assets) -12.9% -7.66% 4.86% 2.61% -1.81% -5.2%
Assets 1 535.5 509.7 1,278 1,692 2,931 3,826
Book Value Per Share 2 2.570 1.800 11.40 12.20 11.50 8.260
Cash Flow per Share 2 0.9400 0.5700 5.860 5.160 4.380 3.620
Capex 1 20.3 1.15 23.3 14.7 248 424
Capex / Sales 8.31% 0.48% 4.89% 2.67% 67.06% 160.11%
Announcement Date 19-04-30 20-04-30 21-04-29 22-04-27 23-04-28 24-04-30
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Diagnostic & Testing Substances

1st Jan change Capi.
GENERAL BIOLOGICALS CORPORATION Stock General Biologicals Corporation
-27.22% 36.25M
BIOMÉRIEUX Stock bioMérieux
-3.58% 12.37B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-1.48% 8.37B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+8.70% 5.84B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+25.61% 5.4B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-4.58% 4.37B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-51.80% 3.23B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+16.25% 2.8B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+30.25% 2.26B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-4.08% 1.87B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 4117 Stock
  4. Financials General Biologicals Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW